Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | EC30 | = | 5.2 | nM | 3361580 |
NPT32 | Organism | Mus musculus | Mus musculus | ID50 | > | 30 | mg/kg | 3361580 |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | IC50 | = | 20000 | nM | 14521410 |
NPT2682 | Individual Protein | Alpha-chymotrypsin | Bos taurus | IC50 | = | 175000 | nM | 14521410 |
NPT2683 | Individual Protein | Malate dehydrogenase cytoplasmic | Homo sapiens | IC50 | = | 50000 | nM | 14521410 |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | IC50 | > | 50 | 14521410 | |
NPT2682 | Individual Protein | Alpha-chymotrypsin | Bos taurus | IC50 | = | 3 | 14521410 | |
NPT654 | Individual Protein | Beta-lactamase | Enterobacter cloacae | IC50 | > | 50 | 14521410 | |
NPT2682 | Individual Protein | Alpha-chymotrypsin | Bos taurus | IC50 | = | 2 | 14521410 | |
NPT2684 | Individual Protein | Malate dehydrogenase mitochondrial | Sus scrofa | IC50 | = | 49 | 14521410 | |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Ki | = | 280 | nM | 14761192 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED30 | = | 3 | ug kg-1 | 2552119 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | ED30 | = | 175 | ug kg-1 | 2552119 |
NPT2685 | Protein Family | Voltage-gated L-type calcium channel | Rattus norvegicus | IC50 | = | 2.66 | nM | 2552119 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 19600 | nM | 8709132 |
NPT1316 | Individual Protein | Adenosine A2a receptor | Rattus norvegicus | Ki | = | 63800 | nM | 8709132 |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | Ki | = | 3250 | nM | 8709132 |
NPT1760 | Individual Protein | Adenosine A3 receptor | Rattus norvegicus | Inhibition | < | 7.94 | % | 8709132 |
NPT1760 | Individual Protein | Adenosine A3 receptor | Rattus norvegicus | Inhibition | = | 27.2 | % | 8709132 |
NPT1760 | Individual Protein | Adenosine A3 receptor | Rattus norvegicus | Ki | = | 11000 | nM | 8709132 |
NPT2686 | Individual Protein | Equilibrative nucleoside transporter 1 | Rattus norvegicus | Ki | = | 5360 | nM | 8709132 |
NPT2 | Others | Unspecified | Ratio | = | 3.38 | 8709132 | ||
NPT2555 | Others | Adenosine receptors; A1 & A3 | Rattus norvegicus | Ratio | = | 1.78 | 8709132 | |
NPT2687 | Others | Adenosine receptor A2a and A3 | Rattus norvegicus | Ratio | = | 5.8 | 8709132 | |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | ID50 | = | 1.90E-09 | nM | 6304312 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | ID50 | = | 1.00E-09 | nM | 6304312 |
NPT2685 | Protein Family | Voltage-gated L-type calcium channel | Rattus norvegicus | Ki | = | 0.84 | nM | 3023614 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | IC50 | = | 1400 | nM | 2542561 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | = | 3600 | nM | 2542561 |
NPT971 | Protein Family | Adrenergic receptor alpha-2 | Homo sapiens | IC50 | > | 10000 | nM | 2542561 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | > | 10000 | nM | 2542561 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 0.026 | nM | 2542561 |
NPT2688 | Organism | Sus scrofa | Sus scrofa | IC50 | = | 0.3 | nM | 2542561 |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | IC50 | = | 20000 | nM | 13678405 |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Inhibition | = | 81 | % | 13678405 |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Inhibition | = | 33 | % | 13678405 |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Inhibition | = | 32 | % | 13678405 |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | IC50 | = | 420 | nM | 12699389 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Activity | = | 18 | nM/mg*min | 12699389 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Inhibition | = | 100 | % | 12699389 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 950 | nM | 12699389 |
NPT1455 | Individual Protein | P-glycoprotein 3 | Mus musculus | IC50 | = | 2500 | nM | 12699389 |
NPT1456 | Individual Protein | P-glycoprotein 1 | Mus musculus | IC50 | = | 8000 | nM | 12699389 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 2300 | nM | 12699389 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | IC50 | = | 1400 | nM | 11206476 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 5128.61 | nM | 17890094 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 4786.3 | nM | 17890094 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 2.75E+11 | nM | 17890094 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 132.05 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 112.51 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 104.77 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 84.62 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 126.59 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 122.6 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 121.03 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 197.46 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 131.58 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 169.02 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 229.64 | % | 18024584 |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 16595.87 | nM | 18678495 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 4786.3 | nM | 18678495 |
NPT150 | Individual Protein | Anthrax lethal factor | Bacillus anthracis | FC | = | 5.6 | 17485504 | |
NPT612 | Individual Protein | Canalicular multispecific organic anion transporter 1 | Homo sapiens | Activity | = | 59 | % | 18457386 |
NPT467 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Mus musculus | EC50 | = | 500 | nM | 20356305 |
NPT2 | Others | Unspecified | Inhibition | = | 61.5 | % | 18223646 | |
NPT2 | Others | Unspecified | Inhibition | = | 0 | % | 18223646 | |
NPT2 | Others | Unspecified | Inhibition | = | 22.7 | % | 18223646 | |
NPT2 | Others | Unspecified | Inhibition | = | 50 | % | 18223646 | |
NPT2 | Others | Unspecified | Inhibition | = | 55 | % | 18223646 | |
NPT2 | Others | Unspecified | Inhibition | = | 88 | % | 18223646 | |
NPT1219 | Organism | Leishmania chagasi | Leishmania chagasi | IC50 | = | 35660 | nM | 20934347 |
NPT1219 | Organism | Leishmania chagasi | Leishmania chagasi | IC50 | = | 22000 | nM | 20934347 |
NPT634 | Organism | Leishmania amazonensis | Leishmania amazonensis | IC50 | = | 26500 | nM | 20934347 |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 21830 | nM | 20934347 |
NPT1208 | Organism | Leishmania braziliensis | Leishmania braziliensis | IC50 | = | 19080 | nM | 20934347 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 10590 | nM | 20934347 |
NPT2679 | Cell Line | LLC-MK2 | Macaca mulatta | IC50 | = | 71590 | nM | 20934347 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 1835.6 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 58047.9 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 18492.7 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 56234.1 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 23280.9 | nM | PubChem BioAssay data set |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 26121.6 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 115820.8 | nM | PubChem BioAssay data set |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 23099.9 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 14581 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 7079.5 | nM | PubChem BioAssay data set | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT800 | Individual Protein | M-phase phosphoprotein 8 | Homo sapiens | Potency | 37685.8 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 1835.5 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 29934.9 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8199.5 | nM | PubChem BioAssay data set | ||
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 6 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 16353.5 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 79432.8 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 16944.1 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 4228.4 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 33587.5 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 1694.4 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 7304.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 16353.5 | nM | PubChem BioAssay data set | ||
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT445 | Individual Protein | Peripheral myelin protein 22 | Rattus norvegicus | Potency | 5102.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 16136.6 | nM | PubChem BioAssay data set | ||
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Inhibition | = | 100 | % | 11082465 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Activity | = | 100 | % | 12699389 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 11700 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 14600 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 17500 | nM | 11145223 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 3200 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 4540 | nM | 12128170 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 5600 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 6600 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 7100 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | > | 25800 | nM | 11716514 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 31238.4 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT622 | Individual Protein | Solute carrier organic anion transporter family member 2B1 | Homo sapiens | Inhibition | = | 31.8 | % | 22541068 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 10.1 | % | 22541068 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 65.1 | % | 22541068 |
NPT2689 | Individual Protein | Indoleamine 2,3-dioxygenase 2 | Mus musculus | Inhibition | >= | 55 | % | 23122865 |
NPT2690 | Tissue | Thoracic artery | Rattus norvegicus | Inhibition | = | 15.9 | % | 10.1007/s00044-007-9078-8 |
NPT1269 | Tissue | Ileum | Rattus norvegicus | Inhibition | = | 70 | % | 10.1007/s00044-007-9078-8 |
NPT2 | Others | Unspecified | Potency | 17229 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13335.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9441.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26601.1 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 23914.5 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 33491.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 26832.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 18833.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 33488.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 25118.9 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 29847 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29847 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13333.2 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 33488.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 9439.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10682.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16360.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30106.5 | nM | PubChem BioAssay data set | ||
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 26601.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 23914.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 31622.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10590.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16785.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12589.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21131.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8412.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6309.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2691 | Individual Protein | Voltage-gated L-type calcium channel alpha-1C subunit | Homo sapiens | IC50 | = | 250 | nM | 22761000 |
NPT2691 | Individual Protein | Voltage-gated L-type calcium channel alpha-1C subunit | Homo sapiens | IC50 | = | 24100 | nM | 22761000 |
NPT2691 | Individual Protein | Voltage-gated L-type calcium channel alpha-1C subunit | Homo sapiens | IC50 | = | 9600 | nM | 22761000 |
NPT2 | Others | Unspecified | Ratio | = | -16 | 21051535 | ||
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | IC50 | = | 3300 | nM | 22328583 |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | IC50 | = | 1590 | nM | 22328583 |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | IC50 | = | 378 | nM | 22328583 |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | IC50 | > | 30000 | nM | 22328583 |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | > | 30000 | nM | 22328583 |
NPT2 | Others | Unspecified | Ratio | = | 0.5 | 21051535 | ||
NPT1463 | Individual Protein | Cytochrome P450 2J2 | Homo sapiens | Activity | = | 8.9 | % | 22328583 |
NPT1463 | Individual Protein | Cytochrome P450 2J2 | Homo sapiens | Activity | = | 5.8 | % | 22328583 |
NPT628 | Individual Protein | Cytochrome P450 2C8 | Homo sapiens | IC50 | = | 1560 | nM | 22328583 |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | = | 13300 | nM | 23033255 |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | IC50 | = | 560 | nM | 23033255 |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | IC50 | = | 660 | nM | 23033255 |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | IC50 | = | 1780 | nM | 23033255 |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | IC50 | = | 380 | nM | 23033255 |
NPT1463 | Individual Protein | Cytochrome P450 2J2 | Homo sapiens | IC50 | = | 1690 | nM | 23033255 |
NPT2 | Others | Unspecified | Ratio | = | 0 | 21051535 | ||
NPT2 | Others | Unspecified | Ratio | = | 16 | 21051535 | ||
NPT2 | Others | Unspecified | AC50 | 28190 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 19952.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 17782.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 12589.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 10000 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC36836 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC63370 |
0.8533 | High Similarity | NPC190945 |
0.7257 | Intermediate Similarity | NPC186669 |
0.7202 | Intermediate Similarity | NPC123241 |
0.717 | Intermediate Similarity | NPC319645 |
0.7143 | Intermediate Similarity | NPC329338 |
0.7143 | Intermediate Similarity | NPC469726 |
0.7095 | Intermediate Similarity | NPC159963 |
0.7076 | Intermediate Similarity | NPC293458 |
0.7059 | Intermediate Similarity | NPC193410 |
0.7033 | Intermediate Similarity | NPC14994 |
0.7022 | Intermediate Similarity | NPC6974 |
0.7018 | Intermediate Similarity | NPC248117 |
0.7011 | Intermediate Similarity | NPC223595 |
0.7011 | Intermediate Similarity | NPC224970 |
0.7011 | Intermediate Similarity | NPC167724 |
0.7006 | Intermediate Similarity | NPC264482 |
0.7006 | Intermediate Similarity | NPC203202 |
0.7 | Intermediate Similarity | NPC61013 |
0.6961 | Remote Similarity | NPC97584 |
0.6951 | Remote Similarity | NPC282578 |
0.6927 | Remote Similarity | NPC99043 |
0.6927 | Remote Similarity | NPC218594 |
0.6919 | Remote Similarity | NPC474058 |
0.6919 | Remote Similarity | NPC25401 |
0.6731 | Remote Similarity | NPC472165 |
0.673 | Remote Similarity | NPC314473 |
0.6706 | Remote Similarity | NPC314223 |
0.6667 | Remote Similarity | NPC36495 |
0.6667 | Remote Similarity | NPC173295 |
0.6647 | Remote Similarity | NPC473329 |
0.6631 | Remote Similarity | NPC316405 |
0.6611 | Remote Similarity | NPC307640 |
0.6596 | Remote Similarity | NPC473298 |
0.6588 | Remote Similarity | NPC242000 |
0.6587 | Remote Similarity | NPC308197 |
0.6578 | Remote Similarity | NPC181928 |
0.6559 | Remote Similarity | NPC49184 |
0.6554 | Remote Similarity | NPC189116 |
0.6545 | Remote Similarity | NPC220151 |
0.6545 | Remote Similarity | NPC19692 |
0.6534 | Remote Similarity | NPC201424 |
0.6519 | Remote Similarity | NPC21752 |
0.6519 | Remote Similarity | NPC210415 |
0.6519 | Remote Similarity | NPC276993 |
0.6519 | Remote Similarity | NPC293255 |
0.6519 | Remote Similarity | NPC181138 |
0.6519 | Remote Similarity | NPC298851 |
0.6519 | Remote Similarity | NPC177261 |
0.65 | Remote Similarity | NPC122235 |
0.6497 | Remote Similarity | NPC99632 |
0.6497 | Remote Similarity | NPC282339 |
0.6494 | Remote Similarity | NPC161827 |
0.6486 | Remote Similarity | NPC288305 |
0.6485 | Remote Similarity | NPC287358 |
0.6485 | Remote Similarity | NPC159722 |
0.6485 | Remote Similarity | NPC77992 |
0.6471 | Remote Similarity | NPC473541 |
0.6471 | Remote Similarity | NPC478039 |
0.6471 | Remote Similarity | NPC322621 |
0.6467 | Remote Similarity | NPC43477 |
0.6467 | Remote Similarity | NPC321211 |
0.6458 | Remote Similarity | NPC34717 |
0.6456 | Remote Similarity | NPC226794 |
0.6452 | Remote Similarity | NPC470317 |
0.6429 | Remote Similarity | NPC475128 |
0.6429 | Remote Similarity | NPC285622 |
0.6417 | Remote Similarity | NPC471742 |
0.6404 | Remote Similarity | NPC176983 |
0.64 | Remote Similarity | NPC473297 |
0.6398 | Remote Similarity | NPC103605 |
0.6398 | Remote Similarity | NPC81092 |
0.6392 | Remote Similarity | NPC90967 |
0.6389 | Remote Similarity | NPC182131 |
0.6384 | Remote Similarity | NPC97380 |
0.6384 | Remote Similarity | NPC310403 |
0.6384 | Remote Similarity | NPC243673 |
0.6384 | Remote Similarity | NPC263709 |
0.6384 | Remote Similarity | NPC63210 |
0.6384 | Remote Similarity | NPC148468 |
0.6369 | Remote Similarity | NPC257490 |
0.6364 | Remote Similarity | NPC469536 |
0.6358 | Remote Similarity | NPC194562 |
0.634 | Remote Similarity | NPC245916 |
0.6335 | Remote Similarity | NPC105114 |
0.6335 | Remote Similarity | NPC239990 |
0.6335 | Remote Similarity | NPC313293 |
0.6335 | Remote Similarity | NPC152850 |
0.6335 | Remote Similarity | NPC5630 |
0.6335 | Remote Similarity | NPC89923 |
0.6335 | Remote Similarity | NPC71933 |
0.6332 | Remote Similarity | NPC87714 |
0.6318 | Remote Similarity | NPC285192 |
0.6316 | Remote Similarity | NPC472242 |
0.6316 | Remote Similarity | NPC260194 |
0.6316 | Remote Similarity | NPC477556 |
0.6313 | Remote Similarity | NPC286871 |
0.6312 | Remote Similarity | NPC470343 |
0.6312 | Remote Similarity | NPC472244 |
0.6311 | Remote Similarity | NPC471197 |
0.6306 | Remote Similarity | NPC279385 |
0.6306 | Remote Similarity | NPC179605 |
0.6303 | Remote Similarity | NPC253476 |
0.6302 | Remote Similarity | NPC22476 |
0.6302 | Remote Similarity | NPC203628 |
0.6298 | Remote Similarity | NPC472114 |
0.6298 | Remote Similarity | NPC472115 |
0.6298 | Remote Similarity | NPC279527 |
0.6298 | Remote Similarity | NPC214960 |
0.6296 | Remote Similarity | NPC52262 |
0.628 | Remote Similarity | NPC471198 |
0.6273 | Remote Similarity | NPC322433 |
0.6273 | Remote Similarity | NPC136453 |
0.6271 | Remote Similarity | NPC29285 |
0.6266 | Remote Similarity | NPC103292 |
0.6264 | Remote Similarity | NPC470971 |
0.6263 | Remote Similarity | NPC469732 |
0.6257 | Remote Similarity | NPC225319 |
0.625 | Remote Similarity | NPC192533 |
0.625 | Remote Similarity | NPC96901 |
0.6243 | Remote Similarity | NPC94602 |
0.6243 | Remote Similarity | NPC52059 |
0.6243 | Remote Similarity | NPC470069 |
0.6242 | Remote Similarity | NPC291962 |
0.6242 | Remote Similarity | NPC177684 |
0.6242 | Remote Similarity | NPC226143 |
0.6237 | Remote Similarity | NPC14849 |
0.6236 | Remote Similarity | NPC153694 |
0.6236 | Remote Similarity | NPC211525 |
0.6234 | Remote Similarity | NPC472164 |
0.6232 | Remote Similarity | NPC15384 |
0.6232 | Remote Similarity | NPC244425 |
0.6231 | Remote Similarity | NPC1464 |
0.6229 | Remote Similarity | NPC243756 |
0.6226 | Remote Similarity | NPC39818 |
0.6223 | Remote Similarity | NPC472163 |
0.6222 | Remote Similarity | NPC253667 |
0.6222 | Remote Similarity | NPC35510 |
0.6222 | Remote Similarity | NPC472121 |
0.622 | Remote Similarity | NPC231382 |
0.622 | Remote Similarity | NPC157311 |
0.6219 | Remote Similarity | NPC246140 |
0.6219 | Remote Similarity | NPC195787 |
0.6212 | Remote Similarity | NPC312870 |
0.6212 | Remote Similarity | NPC199851 |
0.6212 | Remote Similarity | NPC128265 |
0.6212 | Remote Similarity | NPC254240 |
0.6212 | Remote Similarity | NPC294909 |
0.6211 | Remote Similarity | NPC474926 |
0.6205 | Remote Similarity | NPC474121 |
0.6205 | Remote Similarity | NPC21483 |
0.6205 | Remote Similarity | NPC474473 |
0.6205 | Remote Similarity | NPC198205 |
0.6203 | Remote Similarity | NPC147298 |
0.6203 | Remote Similarity | NPC112373 |
0.6203 | Remote Similarity | NPC131450 |
0.6203 | Remote Similarity | NPC258531 |
0.6203 | Remote Similarity | NPC182057 |
0.6203 | Remote Similarity | NPC475094 |
0.6203 | Remote Similarity | NPC161956 |
0.6198 | Remote Similarity | NPC102338 |
0.6198 | Remote Similarity | NPC63199 |
0.6198 | Remote Similarity | NPC196251 |
0.6198 | Remote Similarity | NPC111602 |
0.6198 | Remote Similarity | NPC477998 |
0.6193 | Remote Similarity | NPC138615 |
0.6193 | Remote Similarity | NPC311054 |
0.6193 | Remote Similarity | NPC122106 |
0.6193 | Remote Similarity | NPC265642 |
0.6193 | Remote Similarity | NPC132874 |
0.6193 | Remote Similarity | NPC218733 |
0.6193 | Remote Similarity | NPC112752 |
0.619 | Remote Similarity | NPC477159 |
0.6182 | Remote Similarity | NPC44805 |
0.6182 | Remote Similarity | NPC8761 |
0.6181 | Remote Similarity | NPC232600 |
0.6173 | Remote Similarity | NPC303214 |
0.6173 | Remote Similarity | NPC472293 |
0.6173 | Remote Similarity | NPC314278 |
0.6173 | Remote Similarity | NPC250476 |
0.6167 | Remote Similarity | NPC27904 |
0.6167 | Remote Similarity | NPC93653 |
0.6166 | Remote Similarity | NPC474059 |
0.6163 | Remote Similarity | NPC314186 |
0.6162 | Remote Similarity | NPC472296 |
0.6162 | Remote Similarity | NPC472297 |
0.6162 | Remote Similarity | NPC191310 |
0.6159 | Remote Similarity | NPC280807 |
0.6159 | Remote Similarity | NPC314431 |
0.6159 | Remote Similarity | NPC472245 |
0.6158 | Remote Similarity | NPC478076 |
0.6154 | Remote Similarity | NPC471825 |
0.6154 | Remote Similarity | NPC473837 |
0.615 | Remote Similarity | NPC260075 |
0.6142 | Remote Similarity | NPC198390 |
0.6142 | Remote Similarity | NPC470021 |
0.6141 | Remote Similarity | NPC472118 |
0.614 | Remote Similarity | NPC472241 |
0.6139 | Remote Similarity | NPC477161 |
0.6135 | Remote Similarity | NPC307437 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC36836 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD6571 | Approved |
1.0 | High Similarity | NPD6570 | Approved |
0.96 | High Similarity | NPD7035 | Approved |
0.96 | High Similarity | NPD7036 | Phase 3 |
0.9404 | High Similarity | NPD8007 | Approved |
0.9404 | High Similarity | NPD8008 | Approved |
0.94 | High Similarity | NPD7244 | Discontinued |
0.9375 | High Similarity | NPD6185 | Discontinued |
0.9247 | High Similarity | NPD6758 | Approved |
0.9231 | High Similarity | NPD7940 | Phase 3 |
0.9167 | High Similarity | NPD2923 | Approved |
0.9079 | High Similarity | NPD7114 | Clinical (unspecified phase) |
0.9057 | High Similarity | NPD7775 | Approved |
0.9032 | High Similarity | NPD8003 | Clinical (unspecified phase) |
0.9032 | High Similarity | NPD8002 | Clinical (unspecified phase) |
0.8933 | High Similarity | NPD7670 | Clinical (unspecified phase) |
0.8919 | High Similarity | NPD4607 | Approved |
0.8859 | High Similarity | NPD3352 | Approved |
0.8742 | High Similarity | NPD4513 | Discontinued |
0.8667 | High Similarity | NPD4041 | Approved |
0.8589 | High Similarity | NPD7881 | Approved |
0.8545 | High Similarity | NPD8281 | Discontinued |
0.8533 | High Similarity | NPD2435 | Approved |
0.8387 | Intermediate Similarity | NPD3399 | Approved |
0.8084 | Intermediate Similarity | NPD8006 | Clinical (unspecified phase) |
0.8057 | Intermediate Similarity | NPD7256 | Discontinued |
0.7925 | Intermediate Similarity | NPD2948 | Discontinued |
0.779 | Intermediate Similarity | NPD7476 | Discontinued |
0.776 | Intermediate Similarity | NPD7891 | Discontinued |
0.7714 | Intermediate Similarity | NPD6793 | Clinical (unspecified phase) |
0.7554 | Intermediate Similarity | NPD6532 | Discontinued |
0.7529 | Intermediate Similarity | NPD3435 | Discontinued |
0.75 | Intermediate Similarity | NPD6529 | Discontinued |
0.75 | Intermediate Similarity | NPD3948 | Discontinued |
0.75 | Intermediate Similarity | NPD7591 | Clinical (unspecified phase) |
0.7443 | Intermediate Similarity | NPD3436 | Approved |
0.7382 | Intermediate Similarity | NPD7182 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD5185 | Approved |
0.7355 | Intermediate Similarity | NPD5182 | Approved |
0.7355 | Intermediate Similarity | NPD5184 | Approved |
0.7308 | Intermediate Similarity | NPD4069 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD4068 | Approved |
0.7308 | Intermediate Similarity | NPD4065 | Approved |
0.7308 | Intermediate Similarity | NPD4066 | Approved |
0.7308 | Intermediate Similarity | NPD4067 | Approved |
0.7245 | Intermediate Similarity | NPD6770 | Approved |
0.717 | Intermediate Similarity | NPD1110 | Approved |
0.717 | Intermediate Similarity | NPD1109 | Approved |
0.7152 | Intermediate Similarity | NPD5227 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6637 | Approved |
0.7143 | Intermediate Similarity | NPD5170 | Discontinued |
0.7134 | Intermediate Similarity | NPD1802 | Approved |
0.7134 | Intermediate Similarity | NPD1801 | Approved |
0.7117 | Intermediate Similarity | NPD2887 | Clinical (unspecified phase) |
0.711 | Intermediate Similarity | NPD6786 | Discontinued |
0.7091 | Intermediate Similarity | NPD5942 | Approved |
0.7091 | Intermediate Similarity | NPD5941 | Approved |
0.7063 | Intermediate Similarity | NPD3170 | Approved |
0.7045 | Intermediate Similarity | NPD5919 | Clinical (unspecified phase) |
0.6982 | Remote Similarity | NPD4507 | Discontinued |
0.6909 | Remote Similarity | NPD5166 | Discontinued |
0.6867 | Remote Similarity | NPD1956 | Clinical (unspecified phase) |
0.6865 | Remote Similarity | NPD7235 | Clinical (unspecified phase) |
0.686 | Remote Similarity | NPD4335 | Clinical (unspecified phase) |
0.6845 | Remote Similarity | NPD2737 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD7105 | Phase 1 |
0.6818 | Remote Similarity | NPD2249 | Approved |
0.6818 | Remote Similarity | NPD2247 | Approved |
0.6807 | Remote Similarity | NPD6622 | Phase 1 |
0.6802 | Remote Similarity | NPD7272 | Discontinued |
0.6792 | Remote Similarity | NPD9471 | Clinical (unspecified phase) |
0.679 | Remote Similarity | NPD6294 | Approved |
0.679 | Remote Similarity | NPD6295 | Approved |
0.6786 | Remote Similarity | NPD7528 | Approved |
0.6772 | Remote Similarity | NPD6359 | Clinical (unspecified phase) |
0.6761 | Remote Similarity | NPD3251 | Approved |
0.6748 | Remote Similarity | NPD1626 | Approved |
0.6744 | Remote Similarity | NPD2836 | Approved |
0.6724 | Remote Similarity | NPD7600 | Phase 2 |
0.6708 | Remote Similarity | NPD3373 | Approved |
0.6706 | Remote Similarity | NPD5982 | Phase 2 |
0.6704 | Remote Similarity | NPD7854 | Phase 2 |
0.6687 | Remote Similarity | NPD2670 | Approved |
0.6687 | Remote Similarity | NPD5024 | Approved |
0.6667 | Remote Similarity | NPD2863 | Approved |
0.6667 | Remote Similarity | NPD2918 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD2919 | Clinical (unspecified phase) |
0.6648 | Remote Similarity | NPD7663 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD5993 | Phase 1 |
0.6629 | Remote Similarity | NPD3511 | Discontinued |
0.6624 | Remote Similarity | NPD2198 | Approved |
0.6624 | Remote Similarity | NPD2199 | Approved |
0.6616 | Remote Similarity | NPD4506 | Discontinued |
0.6609 | Remote Similarity | NPD6998 | Discontinued |
0.6606 | Remote Similarity | NPD5068 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD6657 | Clinical (unspecified phase) |
0.6593 | Remote Similarity | NPD5498 | Phase 2 |
0.659 | Remote Similarity | NPD1093 | Approved |
0.659 | Remote Similarity | NPD1092 | Approved |
0.6587 | Remote Similarity | NPD1625 | Approved |
0.6583 | Remote Similarity | NPD5072 | Discontinued |
0.6579 | Remote Similarity | NPD4574 | Approved |
0.6579 | Remote Similarity | NPD4576 | Approved |
0.6575 | Remote Similarity | NPD5466 | Approved |
0.6571 | Remote Similarity | NPD7599 | Phase 2 |
0.6568 | Remote Similarity | NPD6609 | Clinical (unspecified phase) |
0.6566 | Remote Similarity | NPD2010 | Phase 3 |
0.6564 | Remote Similarity | NPD1071 | Clinical (unspecified phase) |
0.6552 | Remote Similarity | NPD6913 | Approved |
0.6545 | Remote Similarity | NPD7142 | Discontinued |
0.6532 | Remote Similarity | NPD5086 | Approved |
0.6519 | Remote Similarity | NPD5997 | Discontinued |
0.6512 | Remote Similarity | NPD7606 | Phase 3 |
0.6491 | Remote Similarity | NPD4888 | Discontinued |
0.6489 | Remote Similarity | NPD4084 | Clinical (unspecified phase) |
0.6488 | Remote Similarity | NPD2820 | Phase 3 |
0.6485 | Remote Similarity | NPD6342 | Discontinued |
0.6481 | Remote Similarity | NPD5581 | Approved |
0.6478 | Remote Similarity | NPD552 | Approved |
0.6478 | Remote Similarity | NPD553 | Approved |
0.6478 | Remote Similarity | NPD9567 | Approved |
0.6471 | Remote Similarity | NPD5162 | Approved |
0.6461 | Remote Similarity | NPD7734 | Approved |
0.6448 | Remote Similarity | NPD6645 | Clinical (unspecified phase) |
0.6441 | Remote Similarity | NPD7275 | Approved |
0.6433 | Remote Similarity | NPD7478 | Approved |
0.6429 | Remote Similarity | NPD3451 | Clinical (unspecified phase) |
0.6429 | Remote Similarity | NPD2365 | Approved |
0.6429 | Remote Similarity | NPD6414 | Clinical (unspecified phase) |
0.6429 | Remote Similarity | NPD6238 | Discontinued |
0.6425 | Remote Similarity | NPD3252 | Approved |
0.6424 | Remote Similarity | NPD3528 | Clinical (unspecified phase) |
0.642 | Remote Similarity | NPD1070 | Approved |
0.642 | Remote Similarity | NPD1069 | Approved |
0.642 | Remote Similarity | NPD6039 | Approved |
0.6413 | Remote Similarity | NPD5334 | Clinical (unspecified phase) |
0.6409 | Remote Similarity | NPD5183 | Approved |
0.6409 | Remote Similarity | NPD5186 | Approved |
0.6406 | Remote Similarity | NPD7429 | Clinical (unspecified phase) |
0.6402 | Remote Similarity | NPD6623 | Phase 3 |
0.6391 | Remote Similarity | NPD4430 | Phase 2 |
0.6387 | Remote Similarity | NPD5042 | Phase 1 |
0.6386 | Remote Similarity | NPD4448 | Approved |
0.6386 | Remote Similarity | NPD4449 | Approved |
0.6378 | Remote Similarity | NPD6479 | Discontinued |
0.6374 | Remote Similarity | NPD7687 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD3625 | Discontinued |
0.6368 | Remote Similarity | NPD7444 | Clinical (unspecified phase) |
0.6364 | Remote Similarity | NPD8658 | Clinical (unspecified phase) |
0.6358 | Remote Similarity | NPD2038 | Approved |
0.6358 | Remote Similarity | NPD2039 | Approved |
0.6354 | Remote Similarity | NPD7569 | Approved |
0.6354 | Remote Similarity | NPD2681 | Approved |
0.6354 | Remote Similarity | NPD2680 | Approved |
0.6354 | Remote Similarity | NPD7570 | Approved |
0.6353 | Remote Similarity | NPD2387 | Approved |
0.6353 | Remote Similarity | NPD7487 | Discontinued |
0.6352 | Remote Similarity | NPD9541 | Approved |
0.6352 | Remote Similarity | NPD9539 | Approved |
0.6348 | Remote Similarity | NPD1012 | Discontinued |
0.6347 | Remote Similarity | NPD7254 | Discontinued |
0.6344 | Remote Similarity | NPD6833 | Clinical (unspecified phase) |
0.6341 | Remote Similarity | NPD1527 | Phase 2 |
0.6341 | Remote Similarity | NPD5747 | Discontinued |
0.6337 | Remote Similarity | NPD7794 | Clinical (unspecified phase) |
0.6333 | Remote Similarity | NPD5430 | Discontinued |
0.6331 | Remote Similarity | NPD1189 | Approved |
0.631 | Remote Similarity | NPD5637 | Discontinued |
0.6296 | Remote Similarity | NPD4549 | Discontinued |
0.6296 | Remote Similarity | NPD8167 | Discontinued |
0.6292 | Remote Similarity | NPD3388 | Phase 1 |
0.6287 | Remote Similarity | NPD4077 | Clinical (unspecified phase) |
0.6284 | Remote Similarity | NPD4150 | Clinical (unspecified phase) |
0.6279 | Remote Similarity | NPD6652 | Clinical (unspecified phase) |
0.6278 | Remote Similarity | NPD3790 | Phase 2 |
0.6275 | Remote Similarity | NPD1374 | Approved |
0.6275 | Remote Similarity | NPD1370 | Approved |
0.6275 | Remote Similarity | NPD1371 | Approved |
0.6275 | Remote Similarity | NPD1373 | Approved |
0.6273 | Remote Similarity | NPD9540 | Approved |
0.6272 | Remote Similarity | NPD4461 | Discontinued |
0.6272 | Remote Similarity | NPD3434 | Clinical (unspecified phase) |
0.627 | Remote Similarity | NPD4091 | Approved |
0.6265 | Remote Similarity | NPD2470 | Clinical (unspecified phase) |
0.6264 | Remote Similarity | NPD5748 | Phase 2 |
0.6258 | Remote Similarity | NPD5202 | Clinical (unspecified phase) |
0.6258 | Remote Similarity | NPD6070 | Approved |
0.6258 | Remote Similarity | NPD6069 | Approved |
0.6257 | Remote Similarity | NPD6211 | Clinical (unspecified phase) |
0.6257 | Remote Similarity | NPD6293 | Clinical (unspecified phase) |
0.6256 | Remote Similarity | NPD4982 | Discontinued |
0.625 | Remote Similarity | NPD2246 | Approved |
0.625 | Remote Similarity | NPD2248 | Approved |
0.6243 | Remote Similarity | NPD7088 | Discontinued |
0.6243 | Remote Similarity | NPD7441 | Clinical (unspecified phase) |
0.6242 | Remote Similarity | NPD1306 | Clinical (unspecified phase) |
0.6242 | Remote Similarity | NPD3535 | Clinical (unspecified phase) |
0.6237 | Remote Similarity | NPD3995 | Approved |
0.6237 | Remote Similarity | NPD3993 | Approved |
0.6237 | Remote Similarity | NPD3992 | Approved |
PubChem CID   | 4474 |
ChEMBL   | CHEMBL1484 |
ZINC   |
Molecular Weight:   | 479.21 |
ALogP:   | 0.9059 |
MLogP:   | 3.33 |
XLogP:   | 6.671 |
# Rotatable Bonds:   | 16 |
Polar Surface Area:   | 111.01 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 35 |